Management of patients with respiratory infections in primary care: Procalcitonin, C-reactive protein or both?

Expert Review of Respiratory Medicine

Volumn 9, Issue 5, 2015, Pages 587-601

  Meili, Marc ^a   Müller, Beat ^a   Kulkarni, Prasad ^b   Schütz, Philipp ^a  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

^b Asclepius Medical Communications LLC   (United States)

Author keywords

Ambulatory care; Antibiotic guidance; Biomarker; C reactive protein; General practice; Primary care; Procalcitonin

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

AMBULATORY CARE; ANTIBIOTIC THERAPY; EMERGENCY CARE; GENERAL PRACTICE; HOSPITAL PATIENT; HUMAN; META ANALYSIS (TOPIC); POINT OF CARE SYSTEM; PRIMARY MEDICAL CARE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; REVIEW; SYSTEMATIC REVIEW (TOPIC); BACTERIAL INFECTIONS; BLOOD; PRIMARY HEALTH CARE; RESPIRATORY TRACT INFECTIONS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOMARKERS; C-REACTIVE PROTEIN; CALCITONIN; HUMANS; PRIMARY HEALTH CARE; PROTEIN PRECURSORS; RESPIRATORY TRACT INFECTIONS;

EID: 84941005051     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.2015.1081063     Document Type: Review

References (58)

1. Goossens H, Ferech MVander Stichele R, et al. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 2005;365(9459):579-87
2. Johnson DM, Stilwell MG, Fritsche TR, et al. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003). Diagn Microbiol Infect Dis 2006;56(1):69-74
3. Md Rezal RS, Hassali MA, Alrasheedy AA, et al. Physicians' knowledge, perceptions and behaviour towards antibiotic prescribing: A systematic review of the literature. Expert Rev Anti Infect Ther 2015;13(5):665-80
4. Sabuncu E, David J, Bernède-Bauduin C, et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med 2009;6(6):e1000084
5. Furst J, C ? i-zman M, Mrak J, et al. The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications. Expert Rev Anti Infect Ther 2015;13(2):279-89
6. Schuetz P, Amin DN, Greenwald JL. Role of procalcitonin in managing adult patients with respiratory tract infections. Chest 2012;141(4):1063-73
7. Tillett WS, Francis T. Serological Reactions in Pneumonia with a Non-Protein Somatic Fraction of Pneumococcus. J Exp Med 1930;52(4):561-71
8. Volanakis JE. Human C-reactive protein: Expression, structure, and function. Mol Immunol 2001 38(2-3):189-97
9. Zouki C, Beauchamp M, Baron C, et al. Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. J Clin Invest 1997;100(3):522-9
10. Gershov D, Kim S, Brot N, et al. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 2000;192(9): 1353-64
11. Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 1992;4(5):361-8
12. Cermak J, Key NS, Bach RR, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82(2):513-20
13. Jones SA, Novick D, Horiuchi S, et al. C-reactive protein: A physiological activator of interleukin 6 receptor shedding. J Exp Med 1999;189(3):599-604
14. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340(6): 448-54
15. Gogos CA, Drosou E, Bassaris HP, et al. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: A marker for prognosis and future therapeutic options. J Infect Dis 2000; 181(1):176-80
16. Christ-Crain M, Muller B. Procalcitonin in bacterial infections-hype, hope, more or less? Swiss Med Wkly 2005;135(31-32): 451-60
17. Christ-Crain M, Muller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 2007; 30(3):556-73
18. Linscheid P, et al. Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue. Endocrinology 2005;146(6):2699-708
19. Schuetz P, Christ-Crain M, Muller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections-hope for hype? Swiss Med Wkly 2009;139(23-24):318-26
20. Becker KL, Nyle-n ES, White JC, et al. Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: A journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004; 89(4):1512-25
21. Karlsson S, Heikkinen M, Pettilä V, et al. Predictive value of procalcitonin decrease in patients with severe sepsis: A prospective observational study. Crit Care 2010;14(6): R205
22. Schuetz P, Mueller B Trampuz A. Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection 2007;35(5):352-5
23. Muller F, Christ-Crain M, Bregenzer T, et al. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: A prospective cohort trial. Chest 2010;138(1):121-9
24. van Nieuwkoop C, Bonten TN, van't Wout JW, et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: A prospective observational study. Crit Care 2010;14(6):R206
25. Muller B, Harbarth S, Stolz D, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007;7:10
26. Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial. Am J Respir Crit Care Med 2006;174(1):84-93
27. Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: The ProHOSP randomized controlled trial. Virulence 2010;1(2):88-92
28. Schuetz P, Suter-Widmer I, Chaudri A, et al. Prognostic value of procalcitonin in community-acquired pneumonia. Eur Respir J 2011;37(2):384-92
29. Kruger S, Ewig S, Marre R, et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 2008;31(2):349-55
30. Huang DT, Weissfeld LA, Kellum JA, et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 2008;52(1): 48-58 e2.
31. Haeuptle J, Zaborsky R, Fiumefreddo R, et al. Prognostic value of procalcitonin in Legionella pneumonia. Eur J Clin Microbiol Infect Dis 2009;28(1):55-60
32. Jensen JU, Heslet L, Jensen TH, et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006;34(10): 2596-602
33. Schuetz P, Chiappa V, Briel M, et al. Procalcitonin algorithms for antibiotic therapy decisions: A systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011;171(15):1322-31
34. Prkno A, Wacker C, Brunkhorst FM, et al. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock-a systematic review and meta-analysis. Crit Care 2013;17(6):R291
35. Jensen JU, Hein L, Lundgren B, et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial. Crit Care Med 2011;39(9):2048-58
36. Aabenhus R, Jensen JU, Jørgensen KJ, et al. Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. Cochrane Database Syst Rev 2014;11: CD010130
37. Andreeva E, Melbye H. Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: An open cluster-randomized clinical trial with C-reactive protein testing in the intervention group. Bmc Family Practice 2014;15
38. Cals JW, Butler CC, Hopstaken RM, et al. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: Cluster randomised trial. BMJ 2009;338:b1374
39. Cals JW, Schot MJ, de Jong SA, et al. Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: A randomized controlled trial. Ann Fam Med 2010;8(2):124-33
40. Diederichsen HZ, Aaraas I, Fleten N, et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scand J Prim Health Care 2000;18(1):39-43
41. Melbye H, et al. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults. Tidsskr Nor Laegeforen 1995; 115(13):1610-15
42. Steurer J, Held U, Spaar A, et al. A decision aid to rule out pneumonia and reduce unnecessary prescriptions of antibiotics in primary care patients with cough and fever. BMC Med 2011;9:56
43. Levy ML, Le Jeune I, Woodhead MA, et al. Primary care summary of the British Thoracic Society Guidelines for the management of community acquired pneumonia in adults: 2009 update. Endorsed by the Royal College of General Practitioners and the Primary Care Respiratory Society UK. Prim Care Respir J 2010;19(1):21-7
44. Held U, Steurer-Stey C, Huber F, et al. Diagnostic aid to rule out pneumonia in adults with cough and feeling of fever. A validation study in the primary care setting. BMC Infect Dis 2012;12:355
45. Calvino O, Llor C, Go-mez F, et al. Association between C-reactive protein rapid test and group A streptococcus infection in acute pharyngitis. J Am Board Fam Med 2014;27(3):424-6
46. Little P, Stuart B, Francis N, et al. Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: A multinational, cluster, randomised, factorial, controlled trial. Lancet 2013;382(9899):1175-82
47. Briel M, Schuetz P, Mueller B, et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008;168(18):2000-7; discussion 2007-8
48. Burkhardt O, Ewig S, Haagen U, et al. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J 2010;36(3):601-7
49. Long W, Deng X, Zhang Y, et al. Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia. Respirology 2011;16(5):819-24
50. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial. Lancet 2004;363(9409):600-7
51. Holm A, Pedersen SS, Nexoe J, et al. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care. Br J Gen Pract 2007;57(540):555-60
52. van Vugt SF, Broekhuizen BD, Lammens C, et al. Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study. BMJ 2013;346:f2450
53. Espan?a PP, Capelastegui A, Bilbao A, et al. Utility of two biomarkers for directing care among patients with non-severe communityacquired pneumonia. Eur J Clin Microbiol Infect Dis 2012;31(12):3397-405
54. Christensen AM, Thomsen MK, Ovesen T, et al. Are procalcitonin or other infection markers useful in the detection of group A streptococcal acute tonsillitis? Scand J Infect Dis 2014;46(5):376-83
55. Michaelidis CI, Zimmerman RK, Nowalk MP, et al. Cost-effectiveness of procalcitonin-guided antibiotic therapy for outpatient management of acute respiratory tract infections in adults. J Gen Intern Med 2014;29(4):579-86
56. Hunter R. Cost-Effectiveness of Point-of-Care C-Reactive Protein Tests for Respiratory Tract Infection in Primary Care in England. Adv Ther 2015. [Epub ahead of print]
57. Streit S, Frey P, Singer S, et al. Clinical and haematological predictors of antibiotic prescribing for acute cough in adults in Swiss practices inverted question mark an observational study. BMC Fam Pract 2015; 16(1):15
58. Kutz A, Grolimund E, Christ-Crain M et al. Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients. BMC Anesthesiol 2014;14:102